DPT Meeting: Panel 1 – Protocol Objectives & Eligibility PANEL Discussion 1: Protocol Objectives and Eligibility Moderators: Abby Bronson, Scott Berry Panelists: Joanne Donovan, MD, PhD, Catabasis Pharmaceuticals Michael Panzara, MD, MPH, Wave Life Sciences Hank Mayer, MD, Children’s Hospital of Philadelphia Paula Clemens, MD, University of Pittsburgh Gretchen Egner, Parent/Advocate 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 5 years ago You may also like 10:23 Cumberland Pharmaceuticals 5 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 7:11 Epirium Bio 5 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 18:36 Sarepta Therapeutics (RNA Targeted Therapies) 5 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 11:46 NS Pharma 5 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 11:20 PTC Therapeutics (Ataluren) 5 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 15:10 Daiichi-Sankyo 5 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 20:43 ReveraGen BioPharma 5 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 12:20 Catabasis 5 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation «1…1920212223…25»Page 21 of 25